Leflunomide for the Treatment of Severe COVID-19 in Patients With a Concurrent Malignancy

Clinical trial NCT04532372 · COMPLETED

Trial details

NCT number: NCT04532372
Sponsor: City of Hope Medical Center
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Hematopoietic and Lymphoid Cell Neoplasm Malignant Solid Neoplasm Symptomatic COVID-19 Infection Laboratory-Confirmed

Start date: 2021-01-07
Primary completion: 2021-08-26
Enrollment: 2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.